Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Worsening a patient's credit can prevent them from getting a job, renting an apartment, or even paying their outstanding ...

A race to develop a new class of drugs could transform treatment for patients with narcolepsy — as well as for patients with ...

Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory bug.

The number of basic science papers published by NIH grant recipients has been falling since 2013, when the agency’s budget was cut by 5%.

University of Minnesota president Rebecca Cunningham is drawing on her experience as an emergency physician in this ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

WASHINGTON — President Trump’s major domestic policy law will result in nearly 10 million more people going without health ...